Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06388148

Endovascular Treatment for eXtra-Large Ischemic Stroke

Efficacy and Safety of Endovascular Thrombectomy Plus Medical Management Versus Medical Management Alone in Acute Ischemic Stroke Patients With Large Vessel Occlusion and Extra-Large Infarct Core: A Multicenter, Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
286 (estimated)
Sponsor
Zhongming Qiu · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The role of endovascular thrombectomy in patients with extra-large ischemic burden is still unclear. The XL STROKE-2 randomized trial is aiming to investigate the efficacy and safety of mechanical thrombectomy in acute extra-large ischemic stroke patients with large vessel occlusion.

Detailed description

Several randomized trials have shown that endovascular thrombectomy improve functional outcomes in acute ischemic stroke patients with large vessel occlusion. Recently, six randomized controlled trials demonstrated the efficacy and safety of endovascular thrombectomy for large infarct patients (defined as Alberta Stroke Program Early Computed Tomography Score \[ASPECTS\] ≥3 or infarct core \<100ml). Patients with extra-large infarct core (volume greater than 100 mL, ASPECTS score of 0 to 2) accounted for a small proportion of these trials. Therefore, the role of endovascular thrombectomy in patients with extra-large ischemic burden is still unclear. That is to say, exactly where the lower limit of endovascular thrombectomy is unknown. The XL STROKE-2 randomized trial is aiming to investigate the efficacy and safety of mechanical thrombectomy in acute extra-large ischemic stroke patients with large vessel occlusion.

Conditions

Interventions

TypeNameDescription
DRUGMedical managementMedical management includes IV thrombolysis, antiplatelet, and/or anticoagulation.
PROCEDUREEndovascular thrombectomyEndovascular thrombectomy with stent-retriever, local aspiration, angioplasty, and/or stenting.

Timeline

Start date
2024-06-16
Primary completion
2026-10-31
Completion
2027-01-31
First posted
2024-04-29
Last updated
2025-12-26

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06388148. Inclusion in this directory is not an endorsement.